Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Akers Biosciences Inc announces pricing of public offering of common stock and listing on NASDAQ


Thursday, 23 Jan 2014 01:05pm EST 

Akers Biosciences Inc:Says the pricing of an underwritten public offering of 2,727,000 shares of common stock at a public offering price of $5.50 per share.Says the shares will begin trading on NASDAQ Capital Market on Jan. 23 at under the symbol AKER.Says it expects to receive about $15,000,000 in gross proceeds, before underwriting discounts and commissions and offering expenses payable by the company.Says it has granted the representative of the underwriters a 45-day option to purchase up to 409,050 additional shares of common stock.Says it intends to use the net proceeds received from the offering for general corporate purposes, including working capital, product development and fulfillment, marketing activities, expansion of internal sales organization, further development of sales channels, and other capital expenditures.Says offering is expected to close on or about January 28, 2014, subject to customary closing conditions.Says Aegis Capital Corp. is acting as sole book-running manager for the offering. 

Company Quote

222.0
2.5 +1.12%
3:01am EST